Literature DB >> 12885909

Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell line.

Rainer Gehrke1, Michael Ecker, Stephan W Aberle, Steven L Allison, Franz X Heinz, Christian W Mandl.   

Abstract

RNA replicons derived from flavivirus genomes show considerable potential as gene transfer and immunization vectors. A convenient and efficient encapsidation system is an important prerequisite for the practical application of such vectors. In this work, tick-borne encephalitis (TBE) virus replicons and an appropriate packaging cell line were constructed and characterized. A stable CHO cell line constitutively expressing the two surface proteins prM/M and E (named CHO-ME cells) was generated and shown to efficiently export mature recombinant subviral particles (RSPs). When replicon NdDeltaME lacking the prM/M and E genes was introduced into CHO-ME cells, virus-like particles (VLPs) capable of initiating a single round of infection were released, yielding titers of up to 5 x 10(7)/ml in the supernatant of these cells. Another replicon (NdDeltaCME) lacking the region encoding most of the capsid protein C in addition to proteins prM/M and E was not packaged by CHO-ME cells. As observed with other flavivirus replicons, both TBE virus replicons appeared to exert no cytopathic effect on their host cells. Sedimentation analysis revealed that the NdDeltaME-containing VLPs were physically distinct from RSPs and similar to infectious virions. VLPs could be repeatedly passaged in CHO-ME cells but maintained the property of being able to initiate only a single round of infection in other cells during these passages. CHO-ME cells can thus be used both as a source for mature TBE virus RSPs and as a safe and convenient replicon packaging cell line, providing the TBE virus surface proteins prM/M and E in trans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885909      PMCID: PMC167216          DOI: 10.1128/jvi.77.16.8924-8933.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Real time quantitative PCR.

Authors:  C A Heid; J Stevens; K J Livak; P M Williams
Journal:  Genome Res       Date:  1996-10       Impact factor: 9.043

2.  Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis.

Authors:  F X Heinz; S L Allison; K Stiasny; J Schalich; H Holzmann; C W Mandl; C Kunz
Journal:  Vaccine       Date:  1995-12       Impact factor: 3.641

3.  A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms.

Authors:  J H Aberle; S W Aberle; S L Allison; K Stiasny; M Ecker; C W Mandl; R Berger; F X Heinz
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

4.  Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form.

Authors:  S L Allison; K Stadler; C W Mandl; C Kunz; F X Heinz
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

5.  Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM.

Authors:  F X Heinz; K Stiasny; G Püschner-Auer; H Holzmann; S L Allison; C W Mandl; C Kunz
Journal:  Virology       Date:  1994-01       Impact factor: 3.616

6.  Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions.

Authors:  J Schalich; S L Allison; K Stiasny; C W Mandl; C Kunz; F X Heinz
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

7.  Characterization of Langat virus antigenic determinants defined by monoclonal antibodies to E, NS1 and preM and identification of a protective, non-neutralizing preM-specific monoclonal antibody.

Authors:  L C Iacono-Connors; J F Smith; T G Ksiazek; C L Kelley; C S Schmaljohn
Journal:  Virus Res       Date:  1996-08       Impact factor: 3.303

8.  Subgenomic replicons of the flavivirus Kunjin: construction and applications.

Authors:  A A Khromykh; E G Westaway
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

9.  Expression of cloned envelope protein genes from the flavivirus tick-borne encephalitis virus in mammalian cells and random mutagenesis by PCR.

Authors:  S L Allison; C W Mandl; C Kunz; F X Heinz
Journal:  Virus Genes       Date:  1994-07       Impact factor: 2.332

10.  Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs.

Authors:  P J Bredenbeek; I Frolov; C M Rice; S Schlesinger
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

View more
  35 in total

1.  Mimicking live flavivirus immunization with a noninfectious RNA vaccine.

Authors:  Regina M Kofler; Judith H Aberle; Stephan W Aberle; Steven L Allison; Franz X Heinz; Christian W Mandl
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

2.  Two distinct size classes of immature and mature subviral particles from tick-borne encephalitis virus.

Authors:  Steven L Allison; Yizhi J Tao; Gabriel O'Riordain; Christian W Mandl; Stephen C Harrison; Franz X Heinz
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

3.  Construction and mutagenesis of an artificial bicistronic tick-borne encephalitis virus genome reveals an essential function of the second transmembrane region of protein e in flavivirus assembly.

Authors:  Klaus K Orlinger; Verena M Hoenninger; Regina M Kofler; Christian W Mandl
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

4.  West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection.

Authors:  Carl W Davis; Hai-Yen Nguyen; Sheri L Hanna; Melissa D Sánchez; Robert W Doms; Theodore C Pierson
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation.

Authors:  Camilo Ansarah-Sobrinho; Steevenson Nelson; Christiane A Jost; Stephen S Whitehead; Theodore C Pierson
Journal:  Virology       Date:  2008-09-17       Impact factor: 3.616

6.  High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery.

Authors:  Francesc Puig-Basagoiti; Tia S Deas; Ping Ren; Mark Tilgner; David M Ferguson; Pei-Yong Shi
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

7.  Recombinant dengue virus-like particles from Pichia pastoris: efficient production and immunological properties.

Authors:  Wenquan Liu; Hanning Jiang; Junmei Zhou; Xiaomeng Yang; Yunxia Tang; Danyun Fang; Lifang Jiang
Journal:  Virus Genes       Date:  2009-11-03       Impact factor: 2.332

8.  Using a Virion Assembly-Defective Dengue Virus as a Vaccine Approach.

Authors:  Chao Shan; Xuping Xie; Jing Zou; Roland Züst; Bo Zhang; Rebecca Ambrose; Jason Mackenzie; Katja Fink; Pei-Yong Shi
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

9.  A mouse cell-adapted NS4B mutation attenuates West Nile virus RNA synthesis.

Authors:  Francesc Puig-Basagoiti; Mark Tilgner; Corey J Bennett; Yangsheng Zhou; Jorge L Muñoz-Jordán; Adolfo García-Sastre; Kristen A Bernard; Pei-Yong Shi
Journal:  Virology       Date:  2006-12-18       Impact factor: 3.616

10.  Tetracycline-inducible packaging cell line for production of flavivirus replicon particles.

Authors:  Tracey J Harvey; Wen Jun Liu; Xiang Ju Wang; Richard Linedale; Michael Jacobs; Andrew Davidson; Thuy T T Le; Itaru Anraku; Andreas Suhrbier; Pei-Yong Shi; Alexander A Khromykh
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.